Survey on reference dosimetry practice in Hokuriku region, Japan.

This study aimed to obtain reference dosimetry practices for flattened photon and electron beams. A questionnaire survey on these practices was sent to 37 facilities that performed radiotherapy using these beams in Fukui, Ishikawa, Niigata and Toyama, Japan. The survey comprised equipment (dosemeters, water phantoms, thermometers, barometers and hygrometers) and procedures for reference dosimetry (water used as the phantoms, verification of chamber placement, periodic checks of ion recombination- and polarity-corrections, pre-irradiation and relative humidity monitoring). Responses were received from 19 institutions. In the 19 institutions, a reference-class dosemeter was used for the reference dosimetry. In 6 of the 19 institutions, a 10-year-old or older dosemeter was used. Any barometers, thermometers and hygrometers were not recalibrated. Dosimetry equipment necessitates regular maintenance. Moreover, it is necessary to have a backup dosimetry system in clinics to account for potential malfunctions or instances when the primary system is sent for calibration.

[18F]FES PET Resolves the Diagnostic Dilemma of COVID-19-Vaccine-Associated Hypermetabolic Lymphadenopathy in ER-Positive Breast Cancer.

Coronavirus disease (COVID-19) vaccination is known to cause a diagnostic dilemma due to false-positive findings on [18F]FDG PET in vaccine-associated hypermetabolic lymphadenopathy. We present two case reports of women with estrogen-receptor (ER)-positive cancer of the breast who were vaccinated for COVID-19 in the deltoid muscle. [18F]FDG positron emission tomography (PET) demonstrated primary breast cancer and multiple axillary lymph nodes with increased [18F]FDG uptake, diagnosed as vaccine-associated [18F]FDG-avid lymph nodes. Subsequent [18F]FES PET revealed single axillary lymph node metastasis in the vaccine-associated [18F]FDG-avid lymph nodes. To the best of our knowledge, this is the first study showing the usefulness of [18F]FES PET in diagnosing axillary lymph node metastasis in COVID-19-vaccinated patients harboring ER-positive breast cancer. Thus, [18F]FES PET has potential applications in the detection of true-positive metastatic lymph nodes in patients with ER-positive breast cancer regardless of the ipsilateral or contralateral side, who have received COVID-19 vaccination.

Evaluation of entrance window deformation in water phantom with window thickness of 5 mm for horizontal beam measurements.

This study aimed to evaluate changes in the deformation of the entrance window on a phantom for a horizontal beam geometry with a window thickness of 5 mm. The window deformation over time was measured using a dial indicator for 12 h after water filling. The window deformation was in the range of 0.17-0.37 mm among the three phantoms. The change in deformation over time was found to be 0.06 mm or less 12 h after filling the phantom. For off-center measurements, the maximum difference in variation among the five points in each of the three phantoms was 0.12, 0.11, and 0.07 mm. The window deformation on the phantom for a horizontal beam geometry with the window thickness of 5 mm was considered almost negligible when appropriately used. However, it is important to control the quality of the phantom according to the usage conditions.

Examining electrometer performance checks with direct-current generator in a clinic: Assessment of generated charges and implementation of electrometer checks.

PURPOSE: Medical physicists use a suitable detector connected to an electrometer to measure radiotherapy beams. Each detector and electrometer has a lifetime (due to physical deterioration of detector components and electrical characteristic deterioration in electronic electrometer components), long-term stability [according to IEC 60731:2011, ≤0.5% (reference-class dosimeter)], and calibration frequency [according to Muir et al. (J Appl Clin Med Phys. 2017; 18:182-190), generally 2 years]; thus, physicists should check the electrometer and detector separately. However, to the best of our knowledge, only one study (Blad et al., Phys Med Biol. 1998; 43:2385-2391) has reported checking the electrometer independently from the detector. The present study conducts performance checks on electrometers separately from the detector in clinical settings, using an electrometer equipped with a direct current (DC) generator (EMF 521R) capable of injecting DC (effective range: ±20 pA to ±20 nA) into itself or another electrometer. METHODS: First, to check the nonlinearity of the generated currents from ±20 pA to ±20 nA, charges generated from the DC generator were measured with the EMF 521R electrometer. Next, six reference-class electrometers classified according to IEC 60731:2011 were checked for repeatability at a current of ±20 pA or a minimum effective indicated value meeting IEC 60731:2011, as well as for nonlinearity within the current range from ±20 pA to ±20 nA. RESULTS: The nonlinearities for the measured currents were less than ±0.05%. The repeatability for the six electrometers was < 0.1%. While the nonlinearity of one electrometer reached up to 0.22% at a current of -20 pA, all six electrometers displayed nonlinearities of less than ±0.1% at currents of ±100 pA or higher. CONCLUSIONS: This work suggests that it is possible to check the nonlinearity and repeatability of clinical electrometers with DCs above the ±30 pA level using a DC generator in a clinic.

Longitudinal assessment of U-shaped and inverted U-shaped developmental changes in the spontaneous movements of infants via markerless video analysis.

Various attempts have been made to elucidate the development patterns in the spontaneous movements of infants through longitudinal evaluations. Movement complexity has been found to demonstrate u-shaped changes in the measurements focusing on limb movements. However, researchers have not yet clarified how other characteristics, besides movement complexity, change over time. This paper presents a longitudinal evaluation of spontaneous movements in infants using evaluation indices calculated through markerless video analysis. Nine infants with corrected ages from [Formula: see text] to 15 weeks participated in the experiments. We confirmed the change in indices over time using statistical methods. Index changes can be classified as positively correlated, u-shaped, inverted u-shaped, and uncorrelated. We also confirmed that the u-shaped and inverted u-shaped indices are negatively correlated. Furthermore, the principal component analysis revealed that the first principal component had the inverted u-shaped changes with the corrected age. These results suggest that it is important to synchronize the inverted u-shaped variations in the movement and velocity with the u-shaped changes in the movement complexity for infant development.

Technical Note: Influence of entrance window deformation on reference dosimetry measurement in various beam modalities.

PURPOSE: Phantoms for horizontal beam geometry can avoid issues in vertical-beam geometry, such as change in chamber depth due to evaporation, and defining the origin at the water surface. However, their thin entrance windows would deform when these phantoms are filled, which can change the chamber depth, as pointed out by The International Atomic Energy Agency (IAEA) TRS-398. Currently, few reports (Arib et al., J Appl Clin Med Phys. 2006; 7:55-64, and Kinoshita et al., Rep Pract Oncol Radiother. 2018; 23:199-206) are available with practical data on window deformation. Therefore, we investigated the influence of entrance window deformation on chamber depths in water phantoms and the measurements in various beam modalities. METHODS: To examine widely used phantoms and phantoms with different characteristics, three phantom types were investigated (the number of phantoms investigated appears in parentheses): PTW-type 41023 (2), Qualita-QWP-04 (2), and IBA-WP34 (2). Prior to the investigation, these phantoms were stored for acclimatization in a room for approximately 10 h under the following two conditions: (a) room temperature: 21 ± 2°C; (b) room temperature: 27 ± 2°C. Using a dial indicator, the centers of the windows were monitored every 30 min for 12 h immediately after the phantoms were filled, in a treatment room at the room temperature of 21 ± 2°C. RESULTS: Immediately after the phantoms were filled, the window deformation ranged from -0.07 (inward-deformation) to 0.3 mm (outward deformation) among the six phantoms, in comparison with empty phantom windows. For 12 h after the phantoms were filled, the change in the deformation was up to 0.23 mm, but typically less than 0.15 mm. CONCLUSIONS: Reference dosimetry in photon, electron, and proton beams would not be influenced significantly by these window behaviors, whereas the window deformation has a slight impact on those heavy ion beams.

Uncertainty in positioning ion chamber at reference depth for various water phantoms.

BACKGROUND: Uncertainty in the calibration of high-energy radiation sources is dependent on user and equipment type. AIM: We evaluated the uncertainty in the positioning of a cylindrical chamber at a reference depth for reference dosimetry of high-energy photon beams and the resulting uncertainty in the chamber readings for 6- and 10-MV photon beams. The aim was to investigate major contributions to the positioning uncertainty to reduce the uncertainty in calibration for external photon beam radiotherapy. MATERIALS AND METHODS: The following phantoms were used: DoseView 1D, WP1D, 1D SCANNER, and QWP-07 as one-dimensional (1D) phantoms for a vertical-beam geometry; GRI-7632 as a phantom for a fixed waterproofing sleeve; and PTW type 41023 and QWP-04 as 1D phantoms for a horizontal-beam geometry. The uncertainties were analyzed as per the Guide to the Expression of Uncertainty in Measurement. RESULTS: The positioning and resultant uncertainties in chamber readings ranged from 0.22 to 0.35 mm and 0.12-0.25%, respectively, among the phantoms (using a coverage factor k = 1 in both cases). The major contributions to positioning uncertainty are: definition of the origin for phantoms among users for the 1D phantoms for a vertical-beam geometry, water level adjustment among users for the phantom for a fixed waterproofing sleeve, phantom window deformation, and non-water material of the window for the 1D phantoms for a horizontal-beam geometry. CONCLUSION: The positioning and resultant uncertainties in chamber readings exhibited minor differences among the seven phantoms. The major components of these uncertainties differed among the phantom types investigated.

Comparison of AAPM Addendum to TG-51, IAEA TRS-398, and JSMP 12: Calibration of photon beams in water.

The American Association of Physicists in Medicine (AAPM) Working Group on TG-51 published an Addendum to the AAPM's TG-51 protocol (Addendum to TG-51) in 2014, and the Japan Society of Medical Physics (JSMP) published a new dosimetry protocol JSMP 12 in 2012. In this study, we compared the absorbed dose to water determined at the reference depth for high-energy photon beams following the recommendations given in AAPM TG-51 and the Addendum to TG-51, IAEA TRS-398, and JSMP 12. This study was performed using measurements with flattened photon beams with nominal energies of 6 and 10 MV. Three widely used ionization chambers with different compositions, Exradin A12, PTW 30013, and IBA FC65-P, were employed. Fully corrected charge readings obtained for the three chambers according to AAPM TG-51 and the Addendum to TG-51, which included the correction for the radiation beam profile (Prp ), showed variations of 0.2% and 0.3% at 6 and 10 MV, respectively, from the readings corresponding to IAEA TRS-398 and JSMP 12. The values for the beam quality conversion factor kQ obtained according to the three protocols agreed within 0.5%; the only exception was a 0.6% difference between the results obtained at 10 MV for Exradin A12 according to IAEA TRS-398 and AAPM TG-51 and the Addendum to TG-51. Consequently, the values for the absorbed dose to water obtained for the three protocols agreed within 0.4%; the only exception was a 0.6% difference between the values obtained at 10 MV for PTW 30013 according to AAPM TG-51 and the Addendum to TG-51, and JSMP 12. While the difference in the absorbed dose to water determined by the three protocols depends on the kQ and Prp values, the absorbed dose to water obtained according to the three protocols agrees within the relative uncertainties for the three protocols.

Effect of Magnesium as Substitute Material in Enzyme-Mediated Calcite Precipitation for Soil-Improvement Technique.

The optimization of enzyme-mediated calcite precipitation was evaluated as a soil-improvement technique. In our previous works, purified urease was utilized to bio-catalyze the hydrolysis of urea, which causes the supplied Ca(2+) to precipitate with [Formula: see text] as calcium carbonate. In the present work, magnesium chloride was newly added to the injecting solutions to delay the reaction rate and to enhance the amount of carbonate precipitation. Soil specimens were prepared in PVC cylinders and treated with concentration-controlled solutions composed of urea, urease, calcium, and magnesium chloride. The mechanical properties of the treated soil specimens were examined through unconfined compressive strength (UCS) tests. A precipitation ratio of the carbonate up to 90% of the maximum theoretical precipitation was achieved by adding a small amount of magnesium chloride. Adding magnesium chloride as a delaying agent was indeed found to reduce the reaction rate of the precipitation, which may increase the volume of the treated soil if used in real fields because of the slower precipitation rate and the resulting higher injectivity. A mineralogical analysis revealed that magnesium chloride decreases the crystal size of the precipitated materials and that another carbonate of aragonite is newly formed. Mechanical test results indicated that carbonate precipitates within the soils and brings about a significant improvement in strength. A maximum UCS of 0.6 MPa was obtained from the treated samples.

[Uncertainty of cross calibration-applied beam quality conversion factor for the Japan Society of Medical Physics 12].

The uncertainty of the beam quality conversion factor (k(Q,Q0)) of standard dosimetry of absorbed dose to water in external beam radiotherapy 12 (JSMP12) is determined by combining the uncertainty of each beam quality conversion factor calculated for each type of ionization chamber. However, there is no guarantee that ionization chambers of the same type have the same structure and thickness, so there may be individual variations. We evaluated the uncertainty of k(Q,Q0) for JSMP12 using an ionization chamber dosimeter and linear accelerator without a specific device or technique in consideration of the individual variation of ionization chambers and in clinical radiation field. The cross calibration formula was modified and the beam quality conversion factor for the experimental values [(k(Q,Q0))field] determined using the modified formula. It's uncertainty was calculated to be 1.9%. The differences between (k(Q,Q0))field of experimental values and k(Q,Q0) for Japan Society of Medical Physics 12 (JSMP12) were 0.73% and 0.88% for 6- and 10-MV photon beams, respectively, remaining within ± 1.9%. This showed k(Q,Q0) for JSMP12 to be consistent with (k(Q,Q0))field of experimental values within the estimated uncertainty range. Although inter-individual differences may be generated, even when the same type of ionized chamber is used, k(Q,Q0) for JSMP12 appears to be consistent within the estimated uncertainty range of (k(Q,Q0)field.

[Comparison of the absorbed dose at calibration depth of photon beams using the Japan Society of Medical Physics 12 beam quality conversion factor in the presence or absence of a waterproofing sleeve].

In standard external beam radiotherapy dosimetry, which is based on absorbed dose by water, the absorbed dose at any calibration depth is calculated using the same beam quality conversion factor, regardless of the presence or absence of a waterproofing sleeve. In this study, we evaluated whether there were differences between absorbed doses at calibration depths calculated using a beam quality conversion factor including a wall correction factor that corresponds to a waterproofing sleeve thickness of 0.3 mm, and without a waterproofing sleeve. The Japan Society of Medical Physics (JSMP) has reported that the uncertainty of the results using a beam quality conversion factor that included a wall correction factor corresponding to a waterproofing sleeve thickness of 0.3 mm, regardless of the presence or absence of the sleeve, was 0.2%. This uncertainty proved to be in agreement with the reported range.

[A comparison of absorbed doses to water in photon beams in Japan Society of Medical Physics 01 and 12].

A comparison of absorbed doses to water at a calibration depth determined by Japan Society of Medical Physics (JSMP) 12 and 01 was conducted, using a farmer type ionization chamber. The absorbed dose to water calibration factor (ND,W,Q0) and beam quality conversion factor (kQ,Q0) for JSMP 12 were smaller than the absorbed dose to water calibration factor and beam quality conversion factor for JSMP 01. Differences in absorbed doses at a calibration depth were -0.78% for 6 MV photon beam and -0.94% for 10 MV photon beam. In the present experiment, absorbed doses at a calibration depth were measured, using a farmer type ionization chamber. Further experiments at a larger number of facilities should be conducted to reveal the status of measurement of absorbed doses at a calibration depth using JSMP 12.

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma.

Epidermal growth factor receptor (EGFR) is commonly overexpressed in malignant pleural mesothelioma (MPM). Cetuximab is a chimeric mouse-human antibody targeted against EGFR and induces potent antibody-dependent cellular cytotoxicity (ADCC). The action of cetuximab against MPM cells has not been well studied. Therefore, in this study, we investigated the antitumor activity of cetuximab against MPM cell lines, particularly with respect to ADCC activity in vitro and in vivo. EGFR expression of MPM cells was measured by a quantitative flow cytometric analysis and immunohistochemistry. The effect of cetuximab on growth inhibition was assessed using a modified MTT assay. The ADCC activity was measured by a 4-h 51Cr release assay using fresh or IL-2-activated peripheral blood mononuclear cells. In vivo antitumor activity of cetuximab was evaluated using an orthotopic implantation mouse model. Cetuximab-mediated ADCC activity against MPM cells was observed at low concentration (0.25 mg/ml) and was enhanced by IL-2, whereas no direct effect on growth inhibition was detected. A logarithmic correlation was observed between the number of EGFRs on MPM cells and ADCC activity. Low EGFR expression on the MPM cells, which was weakly detectable by immunohistochemistry, was sufficient for maximum ADCC activity. In the mouse model, cetuximab treatment with or without IL-2 significantly inhibited intrathoracic tumor growth and prolonged their survival. Our study shows that cetuximab has potent anti-MPM activity both in vitro and in vivo, mainly through the immunologic mechanism of ADCC. Cetuximab has the potential to be used as a novel therapy for MPM patients.

Diagnostic and prognostic impact of serum-soluble UL16-binding protein 2 in lung cancer patients.

UL16-binding protein 2 (ULBP2) is one of the ligands for NKG2D (NKG2DL). ULBP2 expression is induced in transformed cells and is recognized by immune effector cells via the activating NKG2D immunoreceptor. Soluble forms of NKG2DL have been reported in the serum of patients with several types of cancer. The present study investigated the diagnostic and prognostic significance of serum-soluble ULBP2 (sULBP2) in lung cancer patients. We used flow cytometry to evaluate the surface expression of NKG2DL by various lung cancer cells, while sULBP2 was measured using our original ELISA. In addition, the immunological effect of sULBP2 on peripheral blood mononuclear cells (PBMC) was examined by the (51) Cr release assay. We found that ULBP2 was highly expressed and that the sULBP2 level was elevated in supernatants of cultured non-small-cell lung cancer (NSCLC) cells as well as in the serum of NSCLC patients. ULBP2 levels were especially high in squamous cell carcinoma (SQ) patients. Clinical stage IIIB and IV NSCLC patients with a sULBP2 level ≥ 8.7 pg/mL showed significantly shorter survival than patients with sULBP2 <8.7 pg/mL. In multivariate analysis, a sULBP2 level ≥ 8.7 pg/mL (hazard ratio [HR], 2.13; P = 0.038) and clinical stage IV (HR, 2.65; P = 0.019) were independent determinants of a poor outcome. As a possible mechanism, we demonstrated that sULBP2 directly suppresses the cytolytic activity of PBMC. In conclusion, ULBP2 is the most significant NKG2DL for lung cancer, and sULBP2 is useful in the diagnosis of SQ and as a prognostic indicator for patients with advanced NSCLC.

[A study of collimator scatter factors of rectangular irradiation fields using the virtual source plane].

Kim introduced the geometric weighting factor concept into the field mapping method, and estimated collimator scatter factors of rectangular fields by correcting collimator exchange effects. The source plane is present at a specific position in the field mapping method, and, accordingly, the geometric weighting factor is constant. In this study, we changed the position of the source plane based on the measurement results, and we estimated the collimator factors of rectangular fields using the field mapping method. A geometric weighting factor at which the measured collimator scatter factors optimally fitted a square collimator scatter factor was calculated in each field. Collimator scatter factors can be accurately calculated recursively by changing the geometric weighting factor, resulting in altering the position of the source plane, as in this method.